The group will discus and vote on whether to recommend Pfizer booster shots. The Food and Drug Administration's independent advisory committee will convene in open session Friday to review the latest ...

A Centers for Disease Control and Prevention advisory panel on Wednesday voted to recommend Pfizer-BioNTech COVID-19 booster shot for kids ages 12 to 15, a critical step in distributing additional ...

In new data released by the Food and Drug Administration on Wednesday, Pfizer said vaccine booster shots would restore protection against COVID-19 to up to 95% in real-world settings, CNBC and ABC ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. WASHINGTON (Nexstar) — A U.S. Food and Drug ...

Pfizer and BioNTech said Wednesday that initial lab tests show that the omicron variant partly escapes protection offered by the companies' two-dose regimen of their COVID-19 vaccine. However, those ...

Pfizer and BioNTech on Thursday said a booster shot of their COVID-19 vaccine was 95.6% effective in preventing infection from the virus compared to those who did not receive a third dose. In a press ...

NEW YORK - Pfizer has started testing a booster shot of its COVID-19 vaccine in combination with a pneumococcal vaccine candidate, the company announced this week. The company has enrolled 600 fully ...

PHILADELPHIA (WPVI) -- Later this week, the Food and Drug Administration, with a panel of advisers, will decide if booster shots for Moderna and Johnson & Johnson vaccines will be safe for the general ...

Pfizer's CEO confirmed on Twitter that they seek emergency use authorization to provide a second COVID-19 booster shot for adults 65 years and older. Albert Bourla said that they submitted the ...

SAN FRANCISCO (KGO) -- Israel began vaccinating adults considered at risk or immunosuppressed with a third shot, or booster shot, of the Pfizer vaccine on Monday. ABC7 News Reporter Luz Pena ...